Cite
HARVARD Citation
Pacaud, A. et al. (2022). Mogamulizumab‐induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response. Journal of the European Academy of Dermatology and Venereology. pp. e803-e805. [Online].